{"id":523,"date":"2023-10-04T19:33:48","date_gmt":"2023-10-04T19:33:48","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=523"},"modified":"2023-10-11T19:35:24","modified_gmt":"2023-10-11T19:35:24","slug":"bevigilant-orafusion-system-released-in-italy","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/tr\/italyada-piyasaya-surulen-bevigilant-orafuzyon-sistemi\/","title":{"rendered":"BeVigilant\u2122 OraFusion\u2122 Sistemi \u0130talya&#039;da Piyasaya S\u00fcr\u00fcld\u00fc"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033 kilitli=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 arka plan_size=\u201dinitial\u201d arka plan_position=\u201dtop_left\u201d arka plan_repeat=\u201dtekrar\u201d global_colors_info=\u201d{ }\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d g\u00f6renek_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.22.2\u2033 ba\u015fl\u0131k_2_font_size=\u201d24px\u201d ba\u015fl\u0131k_2_line_height=\u201d1.4em\u201d arka plan_size=\u201dinitial\u201d arka plan_pozisyon=\u201dtop_left\u201d arka plan_repeat=\u201dtekrar\u201d \u00f6zel_padding =\u201d25px||||false|false\u201d global_colors_info=\u201d{}\u201d]<\/p>\n<h2>Vigilant Biosciences\u00ae A\u011f\u0131z Kanserine Kar\u015f\u0131 M\u00fccadeleye \u00d6nc\u00fcl\u00fck Ediyor<\/h2>\n<p>Lakeway, Teksas (4 Ekim 2023) \u2013 A\u011f\u0131z kanserinin tespitini h\u0131zland\u0131ran ileri teknoloji \u00e7\u00f6z\u00fcmlerin sekt\u00f6r lideri geli\u015ftiricisi Vigilant Biosciences\u00ae, Inc. (\u201cVigilant\u201d), amiral gemisi \u00fcr\u00fcn\u00fc BeVigilant\u2122&#039;\u0131n piyasaya s\u00fcr\u00fcld\u00fc\u011f\u00fcn\u00fc duyurdu OraFusion\u2122 Sistemi, \u0130talya&#039;da. <\/p>\n<p>BeVigilant\u2122 OraFusion\u2122 Sistemi, bak\u0131m noktas\u0131nda a\u011f\u0131z kanseri risk de\u011ferlendirmesini y\u00f6neten \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir cihazd\u0131r. Sistem, erken a\u015famadaki biyobelirte\u00e7 konsantrasyonlar\u0131n\u0131n ve ak\u0131ll\u0131 yaz\u0131l\u0131m destekli klinik risk fakt\u00f6r\u00fc de\u011ferlendirmesinin birle\u015fik analizi yoluyla do\u011fru bir risk de\u011ferlendirme sonucu sa\u011flar. Bu entegre analiz, \u00f6n saflardaki klinisyenlere oral lezyonlar\u0131 olan hastalar i\u00e7in bilin\u00e7li tedavi kararlar\u0131 vermeleri i\u00e7in gerekli verileri sa\u011flar.<\/p>\n<p>Vigilant Biosciences\u00ae CEO&#039;su Bill Brodie, &quot;Ba\u015f\u0131ndan beri Vigilant, erken te\u015fhis ve m\u00fcdahale yoluyla a\u011f\u0131z kanserinde hayatta kalma oran\u0131n\u0131 art\u0131rmay\u0131 hedefledi&quot; dedi. &quot;BeVigilant\u2122 OraFusion\u2122 Sistemi bu hedefi ger\u00e7e\u011fe d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor ve a\u011f\u0131z kanseri de\u011ferlendirmesinde klinisyenlerin bunu her zamankinden daha erken tespit etmelerine yard\u0131mc\u0131 oluyor. A\u011f\u0131z kanseri tespitini yeniden \u015fekillendirmede bir sonraki ad\u0131m\u0131 atarak teknolojimizin bu hastal\u0131ktan etkilenenlere umut ve hayat kurtar\u0131c\u0131 sonu\u00e7lar getirece\u011fine inan\u0131yoruz.&quot;<\/p>\n<p>Hastalar a\u011f\u0131z kanserinin erken evrelerinde \u00f6zel bak\u0131ma y\u00f6nlendirildiklerinde, tedavi genellikle daha az invaziv ve daha etkili olur ve bu da sonu\u00e7lar\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015fmesine yol a\u00e7ar. Mevcut a\u011f\u0131z kanseri hayatta kalma oran\u0131 50%&#039;dir, ancak erken te\u015fhis hayatta kalma oran\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde 90%&#039;ye kadar art\u0131rabilir. <\/p>\n<p>Vigilant Biosciences\u00ae, erken te\u015fhisi, etkili m\u00fcdahaleyi ve daha iyi sonu\u00e7lar\u0131 g\u00fc\u00e7lendiren basit, do\u011fru ve uygun maliyetli \u00e7\u00f6z\u00fcmlerle a\u011f\u0131z kanserine kar\u015f\u0131 m\u00fccadelede \u00e7\u0131\u011f\u0131r a\u00e7maya devam ediyor. Vigilant Biosciences\u00ae ve \u00fcr\u00fcnleri hakk\u0131nda daha fazla bilgi i\u00e7in l\u00fctfen \u015fu adresi ziyaret edin: <a href=\"https:\/\/vigilantbiosciences.com\/tr\/\">https:\/\/vigilantbiosciences.com\/<\/a>. <\/p>\n<p>Not: BeVigilant\u2122 OraFusion\u2122 Sistemi ABD'de sat\u0131\u015fa sunulmamaktad\u0131r.<\/p>\n<p><strong>Vigilant Biosciences\u00ae, Inc. Hakk\u0131nda<\/strong><br \/>\nVigilant Biosciences\u00ae, a\u011f\u0131z kanserinin erken tespitinde klinisyenlere yard\u0131mc\u0131 olan \u00e7\u00f6z\u00fcmlerin \u00f6nde gelen yenilik\u00e7isi ve geli\u015ftiricisidir. Vigilant'\u0131n BeVigilant\u2122 \u00fcr\u00fcn grubu basit, do\u011fru ve uygun maliyetli bak\u0131m noktas\u0131 testleri i\u00e7erir ve sa\u011fl\u0131k hizmeti uygulay\u0131c\u0131lar\u0131na erken m\u00fcdahale yoluyla hayatlar\u0131 iyile\u015ftirme g\u00fcc\u00fc verir. Vigilant Biosciences\u00ae hakk\u0131nda daha fazla bilgi i\u00e7in: <a href=\"https:\/\/vigilantbiosciences.com\/tr\/\">https:\/\/vigilantbiosciences.com\/<\/a>.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Vigilant Biosciences\u00ae A\u011f\u0131z Kanserine Kar\u015f\u0131 M\u00fccadelede \u00d6nc\u00fcl\u00fck Ediyor Lakeway, Teksas (4 Ekim 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201cVigilant\u201d), a\u011f\u0131z kanserinin tespitini h\u0131zland\u0131ran son teknoloji \u00e7\u00f6z\u00fcmlerin sekt\u00f6r lideri geli\u015ftiricisi, amiral gemisi \u00fcr\u00fcn\u00fc BeVigilant\u2122 OraFusion\u2122 Sisteminin \u0130talya&#039;da piyasaya s\u00fcr\u00fcld\u00fc\u011f\u00fcn\u00fc duyurdu. BeVigilant\u2122 OraFusion\u2122 Sistemi, bir sistemi y\u00f6neten \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir cihazd\u0131r.<\/p>","protected":false},"author":3,"featured_media":527,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/tr\/italyada-piyasaya-surulen-bevigilant-orafuzyon-sistemi\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/tr\/italyada-piyasaya-surulen-bevigilant-orafuzyon-sistemi\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-04T19:33:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T19:35:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dex.manley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"dex.manley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"author\":{\"name\":\"dex.manley\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\"},\"headline\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\",\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"tr\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"description\":\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\",\"name\":\"dex.manley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"caption\":\"dex.manley\"},\"url\":\"https:\/\/vigilantbiosciences.com\/tr\/author\/dex-manley\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/tr\/italyada-piyasaya-surulen-bevigilant-orafuzyon-sistemi\/","og_locale":"tr_TR","og_type":"article","og_title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","og_description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","og_url":"https:\/\/vigilantbiosciences.com\/tr\/italyada-piyasaya-surulen-bevigilant-orafuzyon-sistemi\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2023-10-04T19:33:48+00:00","article_modified_time":"2023-10-11T19:35:24+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg","type":"image\/jpeg"}],"author":"dex.manley","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"dex.manley","Tahmini okuma s\u00fcresi":"2 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"author":{"name":"dex.manley","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357"},"headline":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy","datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"wordCount":431,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"tr"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","url":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357","name":"dex.manley","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","caption":"dex.manley"},"url":"https:\/\/vigilantbiosciences.com\/tr\/author\/dex-manley\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/posts\/523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/comments?post=523"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/posts\/523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/media\/527"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/media?parent=523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/categories?post=523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/tags?post=523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}